Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Claudio Derada Troletti"'
Autor:
Gijs Kooij, Claudio Derada Troletti, Alessandro Leuti, Paul C. Norris, Ian Riley, Maria Albanese, Serena Ruggieri, Stephania Libreros, Susanne M.A. van der Pol, Bert van het Hof, Yoëlle Schell, Gisella Guerrera, Fabio Buttari, Nicola Biagio Mercuri, Diego Centonze, Claudio Gasperini, Luca Battistini, Helga E. de Vries, Charles N. Serhan#, Valerio Chiurchiù#
Publikováno v:
Haematologica, Vol 105, Iss 8 (2020)
Chronic inflammation is a key pathological hallmark of multiple sclerosis (MS) and suggests that resolution of inflammation, orchestrated by specialized pro-resolving lipid mediators (LM), is impaired. Here, through targeted-metabololipidomics in per
Externí odkaz:
https://doaj.org/article/c0a9535b8ffa4ec889d4b21ad22666ee
Autor:
Alessandro Leuti, Paul C. Norris, Gaby Enzmann, Gijs Kooij, Silvia Tietz, Marijn Schouten, Valerio Chiurchiù, Britta Engelhardt, Susanne M. A. van der Pol, Charles N. Serhan, Neda Haghayegh Jahromi, Alwin Kamermans, Claudio Derada Troletti, Helga E. de Vries
Publikováno v:
Cell reports (2021). doi:10.1016/j.celrep.2021.109201
info:cnr-pdr/source/autori:Claudio Derada Troletti 1, Gaby Enzmann 2, Valerio Chiurchiù 3, Alwin Kamermans 4, Silvia Martina Tietz 2, Paul C Norris 5, Neda Haghayegh Jahromi 2, Alessandro Leuti 6, Susanne M A van der Pol 4, Marijn Schouten 4, Charles N Serhan 5, Helga E de Vries 4, Britta Engelhardt 2, Gijs Kooij 7/titolo:Pro-resolving lipid mediator lipoxin A 4 attenuates neuro-inflammation by modulating T cell responses and modifies the spinal cord lipidome/doi:10.1016%2Fj.celrep.2021.109201/rivista:Cell reports/anno:2021/pagina_da:/pagina_a:/intervallo_pagine:/volume
Derada Troletti, C, Enzmann, G, Chiurchiù, V, Kamermans, A, Tietz, S M, Norris, P C, Jahromi, N H, Leuti, A, van der Pol, S M A, Schouten, M, Serhan, C N, de Vries, H E, Engelhardt, B & Kooij, G 2021, ' Pro-resolving lipid mediator lipoxin A4 attenuates neuro-inflammation by modulating T cell responses and modifies the spinal cord lipidome ', Cell Reports, vol. 35, no. 9, 109201 . https://doi.org/10.1016/j.celrep.2021.109201
Derada Troletti, Claudio; Enzmann, Gaby; Chiurchiù, Valerio; Kamermans, Alwin; Tietz, Silvia Martina; Norris, Paul C; Haghayegh Jahromi, Neda; Leuti, Alessandro; van der Pol, Susanne M A; Schouten, Marijn; Serhan, Charles N; de Vries, Helga E; Engelhardt, Britta; Kooij, Gijs (2021). Pro-resolving lipid mediator lipoxin A4 attenuates neuro-inflammation by modulating T cell responses and modifies the spinal cord lipidome. Cell reports, 35(9), p. 109201. Cell Press 10.1016/j.celrep.2021.109201
Cell Reports, 35(9):109201. Cell Press
info:cnr-pdr/source/autori:Claudio Derada Troletti 1, Gaby Enzmann 2, Valerio Chiurchiù 3, Alwin Kamermans 4, Silvia Martina Tietz 2, Paul C Norris 5, Neda Haghayegh Jahromi 2, Alessandro Leuti 6, Susanne M A van der Pol 4, Marijn Schouten 4, Charles N Serhan 5, Helga E de Vries 4, Britta Engelhardt 2, Gijs Kooij 7/titolo:Pro-resolving lipid mediator lipoxin A 4 attenuates neuro-inflammation by modulating T cell responses and modifies the spinal cord lipidome/doi:10.1016%2Fj.celrep.2021.109201/rivista:Cell reports/anno:2021/pagina_da:/pagina_a:/intervallo_pagine:/volume
Derada Troletti, C, Enzmann, G, Chiurchiù, V, Kamermans, A, Tietz, S M, Norris, P C, Jahromi, N H, Leuti, A, van der Pol, S M A, Schouten, M, Serhan, C N, de Vries, H E, Engelhardt, B & Kooij, G 2021, ' Pro-resolving lipid mediator lipoxin A4 attenuates neuro-inflammation by modulating T cell responses and modifies the spinal cord lipidome ', Cell Reports, vol. 35, no. 9, 109201 . https://doi.org/10.1016/j.celrep.2021.109201
Derada Troletti, Claudio; Enzmann, Gaby; Chiurchiù, Valerio; Kamermans, Alwin; Tietz, Silvia Martina; Norris, Paul C; Haghayegh Jahromi, Neda; Leuti, Alessandro; van der Pol, Susanne M A; Schouten, Marijn; Serhan, Charles N; de Vries, Helga E; Engelhardt, Britta; Kooij, Gijs (2021). Pro-resolving lipid mediator lipoxin A4 attenuates neuro-inflammation by modulating T cell responses and modifies the spinal cord lipidome. Cell reports, 35(9), p. 109201. Cell Press 10.1016/j.celrep.2021.109201
Cell Reports, 35(9):109201. Cell Press
The chronic neuro-inflammatory character of multiple sclerosis (MS) suggests that the natural process to resolve inflammation is impaired. This protective process is orchestrated by specialized pro-resolving lipid mediators (SPMs), but to date, the r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0958f3128127b1bba5858f5cc0149cc0
Autor:
Claudio, Derada Troletti, Gaby, Enzmann, Valerio, Chiurchiù, Alwin, Kamermans, Silvia Martina, Tietz, Paul C, Norris, Neda Haghayegh, Jahromi, Alessandro, Leuti, Susanne M A, van der Pol, Marijn, Schouten, Charles N, Serhan, Helga E, de Vries, Britta, Engelhardt, Gijs, Kooij
Publikováno v:
Cell reports
SUMMARY The chronic neuro-inflammatory character of multiple sclerosis (MS) suggests that the natural process to resolve inflammation is impaired. This protective process is orchestrated by specialized pro-resolving lipid mediators (SPMs), but to dat
Autor:
Alessandro Leuti, Paul C. Norris, Gijs Kooij, Serena Ruggieri, Susanne M. A. van der Pol, Stephania Libreros, Nicola Biagio Mercuri, Bert van het Hof, Helga E. de Vries, Gisella Guerrera, Maria Albanese, Valerio Chiurchiù, Ian R. Riley, Diego Centonze, Yoëlle Schell, Claudio Derada Troletti, Luca Battistini, Fabio Buttari, Claudio Gasperini, Charles N. Serhan
Publikováno v:
Haematologica
Chronic inflammation is a key pathological hallmark of multiple sclerosis and suggests that resolution of inflammation, orchestrated by specialized pro-resolving lipid mediators, is impaired. Here, through targeted-metabololipidomics in peripheral bl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29ea36e34036b16ff5daca8e14950a22
http://hdl.handle.net/11573/1408812
http://hdl.handle.net/11573/1408812
Publikováno v:
Biochimica et Biophysica Acta. Molecular Basis of Disease, 1862(3), 452-460. Elsevier
Derada Troletti, C, de Goede, P, Kamermans, A & de Vries, H E 2016, ' Molecular alterations of the blood-brain barrier under inflammatory conditions: The role of endothelial to mesenchymal transition ', Biochimica et Biophysica Acta. Molecular Basis of Disease, vol. 1862, no. 3, pp. 452-460 . https://doi.org/10.1016/j.bbadis.2015.10.010
Derada Troletti, C, de Goede, P, Kamermans, A & de Vries, H E 2016, ' Molecular alterations of the blood-brain barrier under inflammatory conditions: The role of endothelial to mesenchymal transition ', Biochimica et Biophysica Acta. Molecular Basis of Disease, vol. 1862, no. 3, pp. 452-460 . https://doi.org/10.1016/j.bbadis.2015.10.010
Impairment of the protective properties of the blood–brain barrier (BBB) is a key event during numerous neurological diseases, including multiple sclerosis (MS). Under these pathological conditions, the specialized brain endothelial cells (BECs) lo
Autor:
Ruud D. Fontijn, Wendy W. Unger, Dirk Geerts, Marc Charabati, Claudio Derada Troletti, Bert van het Hof, Susanne M. A. van der Pol, Elizabeth Gowing, Alexandre Prat, Melissa A. Lopes Pinheiro, Helga E. de Vries
Publikováno v:
Derada Troletti, C, Lopes Pinheiro, M A, Charabati, M, Gowing, E, van het Hof, B, van der Pol, S M A, Geerts, D, Prat, A, Fontijn, R D, Unger, W W & de Vries, H E 2018, ' Notch signaling is impaired during inflammation in a Lunatic Fringe-dependent manner ', Brain, Behavior, and Immunity, vol. 69, pp. 48-56 . https://doi.org/10.1016/j.bbi.2017.12.016, https://doi.org/10.1016/j.bbi.2017.12.016
Brain Behavior & Immunity, 69, 48-56. Academic Press
Brain, behavior, and immunity, 69, 48-56. Academic Press Inc.
Brain, Behavior, and Immunity, 69, 48-56. Academic Press Inc.
Brain Behavior & Immunity, 69, 48-56. Academic Press
Brain, behavior, and immunity, 69, 48-56. Academic Press Inc.
Brain, Behavior, and Immunity, 69, 48-56. Academic Press Inc.
The blood-brain barrier (BBB) assures brain homeostasis through the specialized function of brain endothelial cells (BECs). Dysfunction of the BBB due to inflammatory processes is associated with several neurological disorders, including multiple scl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7feb0e8f23b13c1972f0689c881dd494
https://research.vumc.nl/en/publications/f7c27b95-85e7-487b-a3e4-2f25bfb00982
https://research.vumc.nl/en/publications/f7c27b95-85e7-487b-a3e4-2f25bfb00982
Autor:
Aric Reijerkerk, Helga E. de Vries, Wouter W. Kamphuis, Claudio Derada Troletti, Ignacio A. Romero
Publikováno v:
Kamphuis, W W, Derada Troletti, C, Reijerkerk, A, Romero, I A & de Vries, H E 2015, ' The Blood-Brain Barrier in Multiple Sclerosis: microRNAs as Key Regulators ', CNS and Neurological Disorders. Drug Targets, vol. 14, no. 2, pp. 157-167 . https://doi.org/10.2174/1871527314666150116125246
CNS and Neurological Disorders. Drug Targets, 14(2), 157-167. Bentham Science Publishers B.V.
Scopus-Elsevier
CNS and Neurological Disorders. Drug Targets, 14(2), 157-167. Bentham Science Publishers B.V.
Scopus-Elsevier
Multiple sclerosis (MS) is a progressive inflammatory disease of the central nervous system (CNS) leading to severe neurological deficits. To date, no treatment is available that halts disease progression, but clinical symptoms can be generally impro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e74ad72c0611079e2a3bdf5225c1a7f
https://research.vumc.nl/en/publications/96fe6e93-0aab-43b4-b14e-1dd4737d0855
https://research.vumc.nl/en/publications/96fe6e93-0aab-43b4-b14e-1dd4737d0855
Autor:
Shamol Saha, Klodjan Stafa, Allison Citro, Hu Li, Patrick Aebischer, Rina Bandopadhyay, Joon Y. Boon, Maria Guillily, Marcie A. Glicksman, Benjamin Wolozin, Claudio Derada Troletti, Zhenyu Yue, Adamantios Mamais, Min Liu, James J. Collins, Katherine L. Youmans, Julien Dusonchet, Darren J. Moore, Li Qun Liu, Bernard L. Schneider, Liliane Glauser
Publikováno v:
Human molecular genetics
Mutations in LRRK2 are one of the primary genetic causes of Parkinson's disease (PD). LRRK2 contains a kinase and a GTPase domain, and familial PD mutations affect both enzymatic activities. However, the signaling mechanisms regulating LRRK2 and the